---
title: "Dataset 32: Brain Tumor Classification from Neuroimaging and Clinical Data"
format: html
---

# Overview

This comprehensive neuroimaging dataset combines MRI scan features with clinical and genetic information to classify brain tumors into four distinct categories. Designed for data science education in medical AI, this dataset presents a realistic multimodal classification challenge that mirrors the complexity of modern neurosurgical decision-making.

::: {.callout-note icon=false}
## Download Dataset

<div style="display: flex; gap: 10px; margin-top: 10px;">
  <a href="../csv/ds032_neuroscience_brain_tumor_type_4_classes.csv" download class="btn btn-primary" style="text-decoration: none; padding: 10px 20px; background-color: #0d6efd; color: white; border-radius: 5px; font-weight: bold;">
    ðŸ“¥ Download Clean Version
  </a>
  <a href="../csv/ds032_neuroscience_brain_tumor_type_4_classes_dirty.csv" download class="btn btn-secondary" style="text-decoration: none; padding: 10px 20px; background-color: #6c757d; color: white; border-radius: 5px; font-weight: bold;">
    ðŸ“¥ Download Dirty Version
  </a>
</div>

**Clean Version**: Complete data with no missing values or outliers
**Dirty Version**: Contains missing values and outliers for data cleaning practice
:::


# Background and Use Case

At Metropolitan Medical Center's Neurosurgery Department, Dr. Sarah Chen leads a team developing an AI-assisted diagnostic system for brain tumor classification. Currently, determining tumor type requires a complex workflow involving radiologists interpreting MRI scans, oncologists reviewing patient symptoms, and pathologists analyzing genetic markers - a process that can take several days and varies significantly between practitioners.

The medical team has collected comprehensive data from 500,000 patients presenting with suspected brain tumors over the past three years. Each case includes quantitative MRI features extracted using advanced imaging software, patient demographics, documented symptoms, genetic biomarker results, and precise tumor location coordinates. The goal is to develop a machine learning model that can rapidly classify tumors into four critical categories that directly impact treatment decisions.

This automated classification system would serve as a clinical decision support tool, helping physicians quickly triage cases, plan surgical approaches, and initiate appropriate treatments while patients are still in the diagnostic phase. The system is particularly valuable for smaller hospitals that may not have immediate access to specialized neuro-oncology expertise.

# Problem Statement

Develop a machine learning model to accurately classify brain tumors into four distinct categories using multimodal clinical data. The model should handle the inherent complexity of neuroimaging data while incorporating diverse clinical features to support rapid, accurate diagnosis in clinical settings.

# Target Variable

**Brain Tumor Type (4 classes)**: This categorical variable represents four clinically distinct tumor classifications:

- **Glioblastoma (Class 0)**: Highly aggressive malignant tumors requiring immediate intensive treatment
- **Meningioma (Class 1)**: Generally benign tumors that may require surgical removal depending on location
- **Pituitary Adenoma (Class 2)**: Hormone-secreting tumors requiring specialized endocrine management
- **Metastatic (Class 3)**: Secondary tumors originating from other body sites, requiring systemic treatment approaches

Accurate classification is critical because each tumor type follows completely different treatment protocols, surgical approaches, and prognosis expectations. Misclassification could lead to inappropriate treatment delays or unnecessarily aggressive interventions.

# Predictor Variables

**MRI Features**: Quantitative measurements extracted from T1-weighted, T2-weighted, and FLAIR MRI sequences including:
- Tumor volume and surface area calculations
- Signal intensity characteristics and contrast enhancement patterns  
- Texture analysis features (homogeneity, entropy, correlation)
- Diffusion tensor imaging metrics indicating tissue microstructure

**Age**: Patient age at diagnosis, crucial for tumor type probability assessment as certain tumors show strong age-related prevalence patterns.

**Symptoms**: Standardized symptom severity scores across multiple domains:
- Neurological deficits (motor weakness, sensory changes)
- Cognitive symptoms (memory issues, confusion, personality changes)
- Physical symptoms (headaches, seizures, nausea/vomiting)
- Duration and progression rate of symptom onset

**Genetic Markers**: Key molecular biomarkers with established clinical relevance:
- IDH1/IDH2 mutation status (critical for glioma classification)
- MGMT promoter methylation levels
- 1p/19q co-deletion status
- Ki-67 proliferation index from biopsy samples

**Tumor Location**: Precise anatomical coordinates and affected brain regions:
- 3D centroid coordinates in standard brain atlas space
- Affected lobes and functional areas
- Proximity to critical structures (eloquent cortex, ventricles)
- Lateralization and hemisphere involvement

# Dataset Versions

This dataset is provided in two versions:

- **Clean Version** (`ds032_neuroscience_brain_tumor_type_4_classes.csv`): Ideal for initial model development and learning fundamental classification techniques without data quality complications
- **Dirty Version** (`ds032_neuroscience_brain_tumor_type_4_classes_dirty.csv`): Contains 2% missing values and 1% outliers, simulating real-world clinical data where some tests may be incomplete, measurements may contain errors, or patient information might be partially unavailable

# Suggested Approaches

**Random Forest**: Excellent for handling mixed data types and providing feature importance rankings to identify which clinical factors most strongly predict tumor type. The ensemble approach is robust to outliers and naturally handles the complex interactions between imaging and clinical features.

**Gradient Boosting (XGBoost/LightGBM)**: Particularly effective for this multimodal problem due to superior performance on heterogeneous tabular data. Can capture complex non-linear relationships between MRI features and clinical variables while providing interpretable feature importance scores.

**Support Vector Machine with RBF Kernel**: Well-suited for the high-dimensional MRI feature space and can effectively separate the four tumor classes in complex feature spaces. Consider feature scaling and potentially dimensionality reduction (PCA) for optimal performance.

# Dataset Details

| Property | Value |
|----------|-------|
| Dataset ID | 32 |
| Domain | Neuroscience |
| Problem Type | Multi-class Classification |
| Number of Rows | 500,000 |
| Number of Features | 28 |
| Class Distribution | Balanced (250 samples per class) |
| Clean Version | `csv/ds032_neuroscience_brain_tumor_type_4_classes.csv` |
| Dirty Version | `csv/ds032_neuroscience_brain_tumor_type_4_classes_dirty.csv` |
| Missing Values (Dirty) | 2% |
| Outliers (Dirty) | 1% |

# Notes

This is a synthetic dataset generated for educational purposes in medical AI and data science. While the data is artificial, the feature relationships, clinical variables, and classification challenges have been designed to reflect realistic patterns found in neurosurgical practice. The dataset provides an excellent opportunity to explore multimodal classification, clinical decision support systems, and the challenges of applying machine learning to medical diagnostic problems.

Students should consider the ethical implications of medical AI, including model interpretability requirements, bias detection, and the importance of clinical validation before any real-world deployment.